940

    500126

    PGHL

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    PROCTER & GAMBLE HEALTH L Share Price Today

    PROCTER & GAMBLE HEALTH L is currently trading at ₹6810, down by ₹44.5 from the previous close. The stock touched an intraday high of ₹6854.00 and a low of ₹6760.00 during the latest trading session. Over the past one year, PROCTER & GAMBLE HEALTH L has delivered a return of 15.75%, while the stock has gained 8.8% in the last one month.

    PROCTER & GAMBLE HEALTH L performance

    Today’s low Today’s high
    ₹ 6760.00 ₹ 6854.00
    ₹ 6799.50
    52 week low 52 week high
    ₹ 4707.00 ₹ 6975.00
    ₹ 6799.50
    Open Price ₹ 6840.00
    Prev. Close ₹ 6854.50
    Volume (Shares) 6998.00
    Total traded value ₹ 475.82
    Upper Circuit ₹ 8225.00
    Lower Circuit ₹ 5484.00
    info

    Investment Returns

    Over 1 Month 8.80% Over 3 Months 35.37% Over 6 Months 24.92% Over 1 Year 15.75%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    PROCTER & GAMBLE HEALTH L fundamentals


    • Market cap (Cr) 11,286.70
    • P/E Ratio (TTM) 34.52
    • Beta 0.44
    • Book Value / share 316.00
    • Return on equity 58.14%
    • EPS (TTM) 196.94
    • Dividend yield 6.11%
    • Net profit/quarter (Cr) 94.60
    info icon alternate text
    • Market cap (Cr) 11,284.10
    • P/E Ratio (TTM) 34.52
    • Beta 0.36
    • Book Value / share 316.00
    • Return on equity 58.14%
    • EPS (TTM) 196.94
    • Dividend yield 6.11%
    • Net profit/quarter (Cr) 94.60
    info icon alternate text

    PROCTER & GAMBLE HEALTH L Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 370.45
    Operating Expense 241.24
    Net Profit 94.60
    Net Profit Margin (%) 25.53
    Earnings Per Share (EPS) 56.99
    EBITDA 139.59
    Effective Tax Rate (%) 28.98
    Particulars DEC 2025 (Values in Cr)
    Revenue 373.86
    Operating Expense 269.40
    Net Profit 77.59
    Net Profit Margin (%) 20.75
    Earnings Per Share (EPS) 46.74
    EBITDA 114.82
    Effective Tax Rate (%) 28.69
    Particulars SEP 2025 (Values in Cr)
    Revenue 324.92
    Operating Expense 210.85
    Net Profit 88.54
    Net Profit Margin (%) 27.24
    Earnings Per Share (EPS) 53.34
    EBITDA 125.22
    Effective Tax Rate (%) 25.60
    Particulars JUN 2025 (Values in Cr)
    Revenue 338.74
    Operating Expense 253.96
    Net Profit 66.18
    Net Profit Margin (%) 19.53
    Earnings Per Share (EPS) 39.87
    EBITDA 94.37
    Effective Tax Rate (%) 25.48
    Particulars MAR 2025 (Values in Cr)
    Revenue 310.99
    Operating Expense 235.57
    Net Profit 61.18
    Net Profit Margin (%) 19.67
    Earnings Per Share (EPS) 36.86
    EBITDA 84.03
    Effective Tax Rate (%) 22.09
    Particulars MAR 2026 (Values in Cr)
    Revenue 1407.97
    Operating Expense 975.44
    Net Profit 326.91
    Net Profit Margin (%) 23.21
    Earnings Per Share (EPS) 196.94
    EBITDA 474.00
    Effective Tax Rate (%) 27.33
    Particulars MAR 2025 (Values in Cr)
    Revenue 934.17
    Operating Expense 632.90
    Net Profit 234.41
    Net Profit Margin (%) 25.09
    Earnings Per Share (EPS) 141.22
    EBITDA 328.74
    Effective Tax Rate (%) 24.77
    Particulars JUN 2024 (Values in Cr)
    Revenue 1151.26
    Operating Expense 873.38
    Net Profit 200.98
    Net Profit Margin (%) 17.45
    Earnings Per Share (EPS) 121.07
    EBITDA 301.44
    Effective Tax Rate (%) 26.46
    Particulars JUN 2023 (Values in Cr)
    Revenue 1229.62
    Operating Expense 933.81
    Net Profit 229.47
    Net Profit Margin (%) 18.66
    Earnings Per Share (EPS) 138.23
    EBITDA 343.07
    Effective Tax Rate (%) 26.96
    Particulars JUN 2022 (Values in Cr)
    Revenue 1114.41
    Operating Expense 874.22
    Net Profit 192.52
    Net Profit Margin (%) 17.27
    Earnings Per Share (EPS) 115.98
    EBITDA 280.87
    Effective Tax Rate (%) 24.01
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 323.47
    ROE % 58.14
    ROCE % 71.75
    Total Debt to Total Equity 0.02
    EBITDA Margin 35.19
    Particulars JUN 2024 (Values in Cr)
    Book Value / Share 324.24
    ROE % 31.18
    ROCE % 39.76
    Total Debt to Total Equity 0.02
    EBITDA Margin 26.18
    Particulars JUN 2023 (Values in Cr)
    Book Value / Share 452.34
    ROE % 33.56
    ROCE % 43.16
    Total Debt to Total Equity 0.01
    EBITDA Margin 27.90
    Particulars JUN 2022 (Values in Cr)
    Book Value / Share 371.38
    ROE % 29.17
    ROCE % 35.97
    Total Debt to Total Equity 0.01
    EBITDA Margin 25.20
    Particulars JUN 2021 (Values in Cr)
    Book Value / Share 423.92
    ROE % 21.96
    ROCE % 27.53
    Total Debt to Total Equity 0.00
    EBITDA Margin 26.18
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 188.55
    Total Assets 794.20
    Total Liabilities 794.20
    Total Equity 536.96
    Share Outstanding 1
    Price to Book Ratio 15.90
    Return on Assets (%) 29.51
    Return on Capital (%) 43.66
    Particulars JUN 2024 (Values in Cr)
    Cash & Short Term Investments 244.36
    Total Assets 794.36
    Total Liabilities 794.36
    Total Equity 538.24
    Share Outstanding 1
    Price to Book Ratio 15.57
    Return on Assets (%) 25.30
    Return on Capital (%) 37.34
    Particulars JUN 2023 (Values in Cr)
    Cash & Short Term Investments 440.22
    Total Assets 1101.19
    Total Liabilities 1101.19
    Total Equity 750.89
    Share Outstanding 1
    Price to Book Ratio 11.60
    Return on Assets (%) 20.83
    Return on Capital (%) 30.56
    Particulars JUN 2022 (Values in Cr)
    Cash & Short Term Investments 324.53
    Total Assets 888.12
    Total Liabilities 888.12
    Total Equity 616.49
    Share Outstanding 1
    Price to Book Ratio 11.27
    Return on Assets (%) 21.67
    Return on Capital (%) 31.23
    Particulars JUN 2021 (Values in Cr)
    Cash & Short Term Investments 468.91
    Total Assets 986.16
    Total Liabilities 986.16
    Total Equity 703.71
    Share Outstanding 1
    Price to Book Ratio 13.20
    Return on Assets (%) 17.92
    Return on Capital (%) 25.12
    Particulars MAR 2025 (Values in Cr)
    Net Income 311.62
    Cash from Operations 250.01
    Cash from Investing 9.59
    Cash from Financing -234.74
    Net change in Cash -56.46
    Free Cash Flow 258.57
    Particulars JUN 2024 (Values in Cr)
    Net Income 273.32
    Cash from Operations 313.48
    Cash from Investing -6.87
    Cash from Financing -418.11
    Net change in Cash -196.69
    Free Cash Flow 335.21
    Particulars JUN 2023 (Values in Cr)
    Net Income 314.20
    Cash from Operations 325.67
    Cash from Investing -21.50
    Cash from Financing -98.49
    Net change in Cash 116.02
    Free Cash Flow 368.15
    Particulars JUN 2022 (Values in Cr)
    Net Income 253.37
    Cash from Operations 233.38
    Cash from Investing -25.54
    Cash from Financing -288.63
    Net change in Cash -144.65
    Free Cash Flow 271.30
    Particulars JUN 2021 (Values in Cr)
    Net Income 233.28
    Cash from Operations 315.38
    Cash from Investing -32.27
    Cash from Financing -386.63
    Net change in Cash -171.64
    Free Cash Flow 367.96
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENTERPRISES L 30.96 12.85 1.49 237.26 23.12 38.85
    BLISS GVS PHARMA LTD. 482.50 38.79 4.28 5117.21 118.35 552.90
    CIPLA LTD 1418.40 30.10 3.32 114584.78 1165.55 1672.20
    FERMENTA BIOTECH LTD. 431.50 19.03 3.12 1269.95 256.40 480.00
    GLAXOSMITHKLINE PHARMACEUTICAL 2455.05 43.22 18.34 41590.03 2088.00 3217.10
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENTERPRISES L 30.96 21.65 3.98 237.26 23.12 38.85
    AMRUTANJAN HEALTH CARE LTD. 537.90 24.11 4.20 1555.10 490.00 789.95
    ASTRAZENECA PHARMA IND LT 8025.95 104.82 22.98 20064.88 7630.00 9850.00
    BLISS GVS PHARMA LTD. 482.50 52.16 4.42 5117.21 118.35 552.90

    PROCTER & GAMBLE HEALTH L shareholding pattern

    Holding
    29.41%
    51.81%
    6.33%
    12.43%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    News

    Left Arrow
    Right Arrow

    PROCTER & GAMBLE HEALTH L Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    6799.50 -0.80 redarrow
    red-green-graph indicator
    2 Bearish
    14 Bullish
    • 5 Days 6803.80
    • 26 Days 6443.90
    • 10 Days 6702.60
    • 50 Days 6149.70
    • 12 Days 6664.40
    • 100 Days 5845.40
    • 20 Days 6531.80
    • 200 Days 5701.60
    6824.83 PIVOT
    First Support 6764.67 First Resistance 6914.67 Second Support 6674.83 Second Resistance 6974.83 Third Support 6614.67 Third Resistance 7064.67
    RSI 68.91 ADX 60.96 MACD 220.48 Williams % R -22.72 Commodity Channel Index (CCI) 95.92
    Date 2026-07-17 Week 20409.00 Same Day 4324.00 Month 13199.00
    1 Year 0.45 3 Year 0.39
    Over 1 Month
    8.80% down
    Over 1 Year
    15.75% down
    Over 3 Months
    35.37% down
    Over 3 Years
    9.73% down
    Over 6 Months
    24.92% down
    Over 5 Years
    4.09% down

    PROCTER & GAMBLE HEALTH L Corporate Actions

    Dividend date Dividend amount Dividend type Record date Instrument type
    27 Aug 2026 45.0 Final 27 Aug 2026 Equity shares
    12 Feb 2026 50.0 Special 12 Feb 2026 Equity shares
    12 Feb 2026 110.0 Interim 12 Feb 2026 Equity shares
    22 Aug 2025 45.0 Final 22 Aug 2025 Equity shares
    21 Feb 2025 80.0 Interim 21 Feb 2025 Equity shares
    28 Nov 2024 60.0 Final 29 Nov 2024 Equity shares
    14 Feb 2024 150.0 Special 14 Feb 2024 Equity shares
    14 Feb 2024 50.0 Interim 14 Feb 2024 Equity shares
    23 Nov 2023 50.0 Final 24 Nov 2023 Equity shares
    13 Feb 2023 45.0 Interim 13 Feb 2023 Equity shares
    15 Nov 2022 11.5 Final 17 Nov 2022 Equity shares
    12 May 2022 41.0 Interim 13 May 2022 Equity shares
    02 Nov 2021 90.0 Special 05 Nov 2021 Equity shares
    02 Nov 2021 40.0 Final 05 Nov 2021 Equity shares
    18 Nov 2020 188.0 Special 20 Nov 2020 Equity shares
    18 Nov 2020 42.0 Final 20 Nov 2020 Equity shares
    23 May 2019 416.0 Special 25 May 2019 Equity shares
    23 May 2019 24.0 Final 25 May 2019 Equity shares
    21 May 2018 15.0 Final 23 May 2018 Equity shares
    25 May 2017 11.0 Final 29 May 2017 Equity shares
    22 Apr 2016 7.5 Final 26 Apr 2016 Equity shares
    30 Mar 2015 6.0 Final 06 Apr 2015 Equity shares
    10 Mar 2014 8.5 Final 12 Mar 2014 Equity shares
    07 Mar 2013 2.5 Final 09 Mar 2013 Equity shares
    22 Oct 2010 95.0 Interim 25 Oct 2010 Equity shares
    18 Mar 2010 20.0 Final 20 Mar 2010 Equity shares
    06 Apr 2009 17.5 Final 09 Apr 2009 Equity shares
    04 Apr 2008 10.0 Final 08 Apr 2008 Equity shares
    21 Mar 2007 10.0 Interim 23 Mar 2007 Equity shares
    21 Mar 2007 20.0 Final 23 Mar 2007 Equity shares
    12 Apr 2006 0.0 Final 15 Apr 2006 Equity shares
    Dividend date Dividend amount Dividend type Record date Instrument type
    27 Aug 2026 45.0 Final 27 Aug 2026 Equity shares
    12 Feb 2026 50.0 Special 12 Feb 2026 Equity shares
    12 Feb 2026 110.0 Interim 12 Feb 2026 Equity shares
    22 Aug 2025 45.0 Final 22 Aug 2025 Equity shares
    21 Feb 2025 80.0 Interim 21 Feb 2025 Equity shares
    28 Nov 2024 60.0 Final 29 Nov 2024 Equity shares
    14 Feb 2024 150.0 Special 14 Feb 2024 Equity shares
    14 Feb 2024 50.0 Interim 14 Feb 2024 Equity shares
    23 Nov 2023 50.0 Final 24 Nov 2023 Equity shares
    13 Feb 2023 45.0 Interim 13 Feb 2023 Equity shares
    15 Nov 2022 11.5 Final 17 Nov 2022 Equity shares
    12 May 2022 41.0 Interim 13 May 2022 Equity shares
    02 Nov 2021 90.0 Special 05 Nov 2021 Equity shares
    02 Nov 2021 40.0 Final 05 Nov 2021 Equity shares
    18 Nov 2020 188.0 Special 20 Nov 2020 Equity shares
    18 Nov 2020 42.0 Final 20 Nov 2020 Equity shares
    23 May 2019 416.0 Special 25 May 2019 Equity shares
    23 May 2019 24.0 Final 25 May 2019 Equity shares
    21 May 2018 15.0 Final 23 May 2018 Equity shares
    25 May 2017 11.0 Final 29 May 2017 Equity shares
    22 Apr 2016 7.5 Final 26 Apr 2016 Equity shares
    30 Mar 2015 6.0 Final 06 Apr 2015 Equity shares
    10 Mar 2014 8.5 Final 12 Mar 2014 Equity shares
    07 Mar 2013 2.5 Final 09 Mar 2013 Equity shares
    22 Oct 2010 95.0 Interim 25 Oct 2010 Equity shares
    18 Mar 2010 20.0 Final 20 Mar 2010 Equity shares
    06 Apr 2009 17.5 Final 09 Apr 2009 Equity shares
    04 Apr 2008 10.0 Final 08 Apr 2008 Equity shares
    21 Mar 2007 10.0 Interim 23 Mar 2007 Equity shares
    21 Mar 2007 20.0 Final 23 Mar 2007 Equity shares
    12 Apr 2006 0.0 Final 15 Apr 2006 Equity shares

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Procter & Gamble Health Ltd?

    Answer Field

    Procter & Gamble Health Ltd share price is for NSE ₹ 6,810.00 & for BSE ₹ 6,790.20 as on Jul 17 2026 03:29 PM.

    What is the Market Cap of Procter & Gamble Health Ltd Share?

    Answer Field

    The market cap of Procter & Gamble Health Ltd for NSE ₹ 11,286.70 & for BSE ₹ 0.00 as on Jul 17 2026 03:29 PM.

    What is the 52 Week High and Low of Procter & Gamble Health Ltd?

    Answer Field

    The 52 Week High and Low of Procter & Gamble Health Ltd for NSE is ₹ 6,975.00 and ₹ 4,707.00 and for BSE is ₹ 6,955.00 and ₹ 4,699.70.

    What is 1 year return for Procter & Gamble Health Ltd?

    Answer Field

    The 1 year returns on the stock has been 15.75%.

    What is the P/E Ratio of Procter & Gamble Health Ltd Share?

    Answer Field

    As on Jul 17 2026 03:29 PM the price-to-earnings (PE) ratio for Procter & Gamble Health Ltd share is 34.52.

    What is the PB ratio of Procter & Gamble Health Ltd Share?

    Answer Field

    As on Jul 17 2026 03:29 PM, the price-to-book (PB) ratio for Procter & Gamble Health Ltd share is 316.00.

    How to Buy Procter & Gamble Health Ltd Share?

    Answer Field

    You can trade in Procter & Gamble Health Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Procter & Gamble Health Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Procter & Gamble Health Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Procter & Gamble Health Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |